The Effects of Endotracheal Suctioning on Pain and Serum Markers

NCT ID: NCT06692400

Last Updated: 2025-05-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

110 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-30

Study Completion Date

2026-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this experimental study is to understand if endotracheal tube (ETT) suctioning increases pain and causes stress on the body in intubated adult ICU patients. These patients are already on ventilators, which means they need suctioning to keep their airways clear, but this procedure may be uncomfortable and cause stress.

The main questions this study aims to answer are:

Does ETT suctioning raise pain levels as measured by the Critical-Care Pain Observation Tool (CPOT)? Does ETT suctioning increase certain chemicals in the blood (hypoxanthine, xanthine, and uric acid) that show stress and lack of oxygen in the body? Researchers will compare patients who have ETT suctioning (intervention group) with those who do not have suctioning during the study period (control group) to see if there are differences in pain and blood markers of stress.

Participants will:

Have pain measured before and after suctioning using the CPOT. Have blood samples taken from an existing line at three time points: 5 minutes before, 5 minutes after, and 30 minutes after suctioning.

Provide demographic information (like age, gender, and diagnosis) from medical records.

This research will help improve how pain is managed for ICU patients who cannot speak for themselves, potentially leading to better pain relief methods in the future.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intensive Care Unit ICU Intubation Critical Illness Mechanical Ventilation Pain Measurement Pain, Procedural Oxidative Stress Hypoxia Biomarkers / Blood Adult Uric Acid Sepsis COVID Influenza Pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Investigators
The lab technician who results the labs will be blinded.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants who undergo endotracheal tube (ETT) suctioning.

Participants will receive ETT suctioning as part of routine care.

Group Type EXPERIMENTAL

endotracheal tube suctioning

Intervention Type PROCEDURE

Endotracheal tube suctioning occurs as part of normal care for intubated patients. This procedure will serve as the painful procedure to assess CPOT and biomarkers of hypoxia and oxidative stress.

Participants who do not undergo ETT suctioning during the observation period.

Participants will not receive ETT suctioning during the observation periood.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

endotracheal tube suctioning

Endotracheal tube suctioning occurs as part of normal care for intubated patients. This procedure will serve as the painful procedure to assess CPOT and biomarkers of hypoxia and oxidative stress.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults (aged 18 years and older)
* Current diagnosis of flu, pneumonia, COVID, or sepsis
* Intubated and receiving mechanical ventilation.
* Have arterial lines placed
* Require endotracheal suctioning as part of their care

Exclusion Criteria

* Patients receiving neuromuscular blocking agents
* Contraindications for blood draws (hemoglobin levels below 8.0 g/dL; Jehovah's Witness)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Loma Linda University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elizabeth Johnston Taylor, PhD, FAAN

Role: PRINCIPAL_INVESTIGATOR

Loma Linda University School of Nursing

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Loma Linda University Medical Center Troesh Medical Campus

Loma Linda, California, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Briana Carr, PhD(c), BSN, RN

Role: CONTACT

909-558-4000

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Loma Linda University Health

Role: primary

877-558-6248

References

Explore related publications, articles, or registry entries linked to this study.

Angeles DM, Boskovic DS, Tan JC, Shih W, Hoch E, Forde D, Phillips RM, Hopper A, Deming DD, Goldstein M, Truong G, Febre A, Pegis P, Lavery A, Kadri M, Banerji A, Mousselli I, Farha V, Fayard E. Oral dextrose reduced procedural pain without altering cellular ATP metabolism in preterm neonates: a prospective randomized trial. J Perinatol. 2020 Jun;40(6):888-895. doi: 10.1038/s41372-020-0634-0. Epub 2020 Feb 26.

Reference Type BACKGROUND
PMID: 32103160 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5240556

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Intubated ICU Patients
NCT02171091 TERMINATED
A Pilot Study Swiftsure
NCT05578599 COMPLETED NA
Recruitment Maneuver After Intubation
NCT01014299 COMPLETED PHASE4